MiNDERA

MiNDERA is developing a breakthrough technology to extract skin biomarkers in a non-invasive manner (no biopsy required). At the core of our products is a proprietary micro-needle array devices that enables pain free, non-invasive and targeted extraction of biomarkers from the skin (e.g. mRNA), without requiring a skin biopsy. These biomarkers are then eluted and analyzed by molecular techniques including PCR and next-generation sequencing to deliver a molecular profile of the sampled region.